Something reviewed and published in a medical journal? I've seen a lot of conjecture and theory. Nothing concrete.
There's plenty. Just search on research gate. Very easy
Something reviewed and published in a medical journal? I've seen a lot of conjecture and theory. Nothing concrete.
Seriously this kind of talk is dangerous. The reason being is that someone can take this literally who is uninformed but it's the internet so I guess broscience is at play. Here's a peer reviewed research article for you. I'm in a M.S program at a University so I used my University research database to locate it for you.
Wimmer, R., Hohenester, S., Pusl, T., Denk, G. U., Rust, C., & Beuers, U. (2008). Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC[alpha]-/PKA-dependent mechanism in rat liver.
Conclusion of the study:
Taurolithocholic acid (TLCA) is the most potent cholestatic agent among the major human bile acids 23 and has recently been shown to exert its cholestatic action at the hepatocyte level by phosphatidylinositol-3-kinase, and putatively nPKC[epsilon]-dependent mechanisms in isolated perfused rat livers (IPRLs) and isolated rat hepatocyte couplets
RESULTS
Bile flow
TLCA (10 μmol/l) reduced bile flow in isolated perfused rat livers (IPRLs) to 14% of controls ( figs 1A,B and 2A ). TUDCA (25 μmol/l) reversed TLCA-induced inhibition of bile flow to 173% of controls. The nonselective PKC inhibitor staurosporine (10 nmol/l), the selective cPKC inhibitor Gö6976 (100 nmol/l), and the selective PKA inhibitor H89 (100 nmol/l) did not significantly affect bile flow in either control livers or in livers treated with TLCA+TUDCA ( figs 1A,B and 2A ). In contrast, when administered concomitantly, staurosporine+H89 as well as Gö6976+H89 induced a significant reduction of bile flow in livers treated with TLCA+TUDCA by 48% (p<0.01) and 36% (p<0.05), respectively, but again, did not affect bile flow in controls or livers treated with TUDCA only ( figs 1A-C and 2A ).